NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/11/2025
Voltar para busca
Dado oficial do USPTO
TREELINE BIOSCIENCES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
TREELINE BIOSCIENCES
ST13
US500000090981524Classe
5, 42
Pedido
90981524
Registro
8042862
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
59
Atualização mais recente
26/11/2025
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
22/04/2021
Data de registro
25/11/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/11/2025
Última transação
26/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
27/12/2024
Primeiro uso no comércio
27/12/2024
Código do desenho
4
Tipo de titular
03
Localização do titular
Watertown, MA
Examinador
NGUYEN,NICOLE ASHLEY
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Treeline Biosciences, Inc.
Treeline Biosciences, Inc.
Representantes
Caitlin R. Byczko Barnes & Thornburg LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical productspreparations for the prevention and treatment of cancerlymphomas
Classe 42
pharmaceutical research and development in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; medicalpharmaceuticalscientific research in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; medicalpharmaceuticalscientific research in the field of biomarkers for use in diagnosingpreventingtreating diseases and disordersnamely cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosingpreventingtreating diseases and disordersnamely cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
59 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
25/11/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/11/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
31/10/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
31/10/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/10/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/05/2025
EX4G
SOU EXTENSION 4 GRANTED
20/05/2025
IUAF
USE AMENDMENT FILED
16/05/2025
EEXT
SOU TEAS EXTENSION RECEIVED
16/05/2025
EXT4
SOU EXTENSION 4 FILED
15/05/2025
DRRR
DIVISIONAL REQUEST RECEIVED
17/01/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
17/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
17/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/12/2024
EX3G
SOU EXTENSION 3 GRANTED
11/12/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/12/2024
EXT3
SOU EXTENSION 3 FILED
12/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/06/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/05/2024
EX2G
SOU EXTENSION 2 GRANTED
06/05/2024
EXT2
SOU EXTENSION 2 FILED
06/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2024
DOCK
ASSIGNED TO EXAMINER
12/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/10/2023
EX1G
SOU EXTENSION 1 GRANTED
03/10/2023
EXT1
SOU EXTENSION 1 FILED
03/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/03/2023
PUBO
PUBLISHED FOR OPPOSITION
21/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/02/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/08/2022
GNFR
FINAL REFUSAL E-MAILED
10/08/2022
CNFR
FINAL REFUSAL WRITTEN
10/08/2022
DOCK
ASSIGNED TO EXAMINER
14/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/12/2021
GNRT
NON-FINAL ACTION E-MAILED
22/12/2021
CNRT
NON-FINAL ACTION WRITTEN
22/12/2021
DOCK
ASSIGNED TO EXAMINER
16/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/10/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/10/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/07/2021
NWAP
NEW APPLICATION ENTERED
26/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TREELINE BIOSCIENCES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.